PROSPECTS OF USING THE COMBINED PREPARATION OF COLPOCID IN THE TREATMENT OF CERVICAL PATHOLOGY ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
Main Article Content
Abstract
Рurpose of the study – to assess the state of the cervix in dynamics with papillomovirus infection in women who received and did not receive colpocid treatmen
Subjects and methods. After a comprehensive examination, the effectiveness of the treatment methods was compared in two comparison groups (n = 50 and n = 50). The results of microscopic, bacteriological, molecular-biological, cytological methods and colposcopy were evaluated before and after therapy in groups with and without the usage of the colposide preparation.
Results. A high (88 %) efficacy of PVI therapy with the usage of the colpocid preparation was demonstrated with an evaluation of the result at 6 and 12 months. In cases where patients were receiving destructive methods of treatment in postoperative period none of the presented cases had complications. Epithelialization had been proceeded under the fibrin film and was achieved by 28-30 days in 100 % of cases
Conclusion. The usage of the vaginal gel which is based on lipoteichoic and glycyrizic acids in cases where patients have had HPV associated with cervical pathology, makes it possible to accelerate the elimination of HPV, provides healing of the cervix after destructive methods of treatment without scarring and bleeding.Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Podzolkova NM, Rogovskaja SI, Fadeev IE. Papillomavirus infection: what's new? Ginekologija. 2011; 13(5): 39-45. Russian (Подзолкова Н.М., Роговская С.И., Фадеев И.Е. Папилломавирусная инфекция: что нового? //Гинекология. 2011. Т. 13, № 5. С. 39-45)
Rogovskaja SI. Topical issues of diagnosis and treatment of cervical pathology. Medicinskie aspekty zdorov'ja zhenshhiny. 2012; 5(57): 5-8. Russian (Роговская С.И. Актуальные вопросы диагностики и лечения патологии шейки матки //Медицинские аспекты здоровья женщины. 2012. № 5(57). С. 5-8)
Bebneva TN, Prilepskaja VN. Prevention of cervical cancer: screening (literature review). Doktor.Ru. 2009; 6(50): 11-17. Russian (Бебнева Т.Н., Прилепская В.Н. Профилактика рака шейки матки: скрининг (обзор литературы) //Доктор.Ру. 2009. № 6(50). С. 11-17)
Brown D. HPV type 6/11/16/18 vaccine: first analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16/18. The 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. 2007, Sep. 17-20
Castellsagu'e X, Diaz M, de Sanjose S et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer. Inst. 2006; 98: 303-315
Nazarova EL, Jovdij AV. Treatment of patients with latent form of papillomavirus infection. Gynecology, Obstetrics and Perinatology. 2008; 7(5): 47-51. Russian (Назарова Е.Л., Йовдий А.В. Лечение больных латентной формой папилломавирусной инфекции //Вопросы гинекологии, акушерства и перинатологии. 2008. Т. 7, № 5. С. 47-51)
Protocol of management of patients with cervical pyloriemia high oncogenic risk. Protokoly vedenija bol'nyh. Infekcii, peredavaemye polovym putem. M.: N'judiamed, 2011. P. 285-331. Russian (Протокол ведения больных с ПВИ шейки матки высокого онкогенного риска. Протоколы ведения больных. Инфекции, передаваемые половым путем. М.: Ньюдиамед, 2011. С. 285-331)
Makarov IO, Shemanaeva TV, Sheshukova NA. The experience of using isoprinosine in the treatment of cervical pathology of inflammatory etiology. Consilium Medicum. 2010; 13(6): 16-18. Russian (Макаров И.О., Шеманаева Т.В., Шешукова Н.А. Опыт применения изопринозина в лечении патологии шейки матки воспалительной этиологии //Consilium Medicum. 2010. Т. 13, № 6. С. 16-18)
Mynbaev OA, Eliseeva MJu. Auxiliary immunotherapy of HPV-associated skin and mucous membrane damage (literature review). Ginekologija. 2011; 13(3): 32-41. Russian (Мынбаев О.А., Елисеева М.Ю. Вспомогательная иммунотерапия ВПЧ-ассоциированных поражений кожи и слизистых оболочек (обзор литературы) //Гинекология. 2011. Т. 13, № 3. С. 32-41)
Prilepskaja VN, Kostava MN. Possibilities of therapy of papillomavirus infection. Russian Medical Journal. 2009; 17(1): 16-19. Russian (Прилепская В.Н., Костава М.Н. Возможности терапии папилломавирусной инфекции //РМЖ. 2009. № 17(1). С. 16-19)
Solov'ev AM. Immunotherapy with isoprinosine as an adjuvant or independent method of treatment for patients with papilloma viral infection. Vestnik Dermatologii i Venerologii. 2011; (5): 146-151. Russian (Соловьев А.М. Иммунотерапия изопринозином как адьювантный или самостоятельный способ лечения больных папилломавирусной инфекцией //Вестник дерматологии и венерологии. 2011. № 5. С. 146-151)
Haitov RM, Haitov MR, Shilovskij IP. Interferons of Type III. Biology Bulletin Reviews. 2010; 130(2): 147-153. Russian (Хаитов Р.М., Хаитов М.Р., Шиловский И.П. Интерфероны третьего типа //Успехи современной биологии. 2010. Т. 130, № 2. С. 147-153)
Cygankova OJu, Novikov AI. Infections of the urogenital system and HPV-associated pathology of the cervix. The Russian Journal of Clinical Dermatology and Venereology. 2009; 6: 50-52. Russian (Цыганкова О.Ю., Новиков А.И. Инфекции органов мочеполовой системы и ВПЧ-ассоциированная патология шейки матки //Клиническая дерматология и венерология. 2009. № 6. С. 50-52)
Andosova LD, Kontorshhikova KN, Kachalina TS. et al. Papillomavirus infection and cervical disease: schoolbook. N-Novgorod: Izd-vo NGMA, 2011. 108 p. Russian (Андосова Л.Д., Конторщикова К.Н., Качалина Т.С. и др. Папилломавирусная инфекция и заболевания шейки матки: учебное пособие. Н-Новгород: Изд-во НГМА, 2011. 108 с.)